CA2994432A1 - Systeme d'authentification utilise dans un systeme de dialyse a base de sorbant pour l'optimisation d'une therapie - Google Patents
Systeme d'authentification utilise dans un systeme de dialyse a base de sorbant pour l'optimisation d'une therapie Download PDFInfo
- Publication number
- CA2994432A1 CA2994432A1 CA2994432A CA2994432A CA2994432A1 CA 2994432 A1 CA2994432 A1 CA 2994432A1 CA 2994432 A CA2994432 A CA 2994432A CA 2994432 A CA2994432 A CA 2994432A CA 2994432 A1 CA2994432 A1 CA 2994432A1
- Authority
- CA
- Canada
- Prior art keywords
- dialysis
- component
- authentication
- patient
- cartridge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000502 dialysis Methods 0.000 title claims abstract description 360
- 239000002594 sorbent Substances 0.000 title claims abstract description 98
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 33
- 238000005457 optimization Methods 0.000 title description 15
- 239000003550 marker Substances 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 42
- 239000000463 material Substances 0.000 claims description 34
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 12
- 230000017531 blood circulation Effects 0.000 claims description 11
- 238000000108 ultra-filtration Methods 0.000 claims description 10
- 238000001631 haemodialysis Methods 0.000 claims description 9
- 230000000322 hemodialysis Effects 0.000 claims description 9
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- 238000003860 storage Methods 0.000 description 53
- 238000011282 treatment Methods 0.000 description 37
- 230000000670 limiting effect Effects 0.000 description 25
- 230000008569 process Effects 0.000 description 24
- 238000011049 filling Methods 0.000 description 21
- 239000012530 fluid Substances 0.000 description 18
- 230000001681 protective effect Effects 0.000 description 17
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 230000006854 communication Effects 0.000 description 16
- 238000004891 communication Methods 0.000 description 14
- 239000012528 membrane Substances 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 11
- 150000001768 cations Chemical class 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 230000004044 response Effects 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 208000001953 Hypotension Diseases 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 208000021822 hypotensive Diseases 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 230000000116 mitigating effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000004159 blood analysis Methods 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000003890 fistula Effects 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000012958 reprocessing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000002615 hemofiltration Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1694—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid
- A61M1/1696—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid with dialysate regeneration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3569—Range sublocal, e.g. between console and disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6009—General characteristics of the apparatus with identification means for matching patient with his treatment, e.g. to improve transfusion security
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6018—General characteristics of the apparatus with identification means providing set-up signals for the apparatus configuration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6054—Magnetic identification systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6063—Optical identification systems
- A61M2205/6072—Bar codes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- External Artificial Organs (AREA)
Abstract
L'invention concerne un système d'authentification et de gestion de dialyse comprenant au moins un composant de dialyse sur lequel est fixé au moins un composant d'authentification. Le composant de dialyse peut être l'un quelconque parmi un dialyseur, une cartouche de sorbant, un dispositif de recharge ou tout autre composant de dialyse. Le composant d'authentification peut être choisi dans le groupe constitué d'un marqueur d'identification radiofréquence, d'un code à barres, d'un composant de sécurité à un fil et d'un composant d'authentification sans fil. Le système d'authentification peut garantir que tous les composants utilisés sont dans un état utilisable et/ou certifié approprié. Le système peut également gérer la recharge des composants rechargeables, et éventuellement gérer la thérapie de dialyse.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/838,112 | 2015-08-27 | ||
| US14/838,112 US9764076B2 (en) | 2014-02-26 | 2015-08-27 | Authentication system utilized in a sorbent-based dialysis system for therapy optimization |
| PCT/US2016/048814 WO2017035420A1 (fr) | 2015-08-27 | 2016-08-26 | Système d'authentification utilisé dans un système de dialyse à base de sorbant pour l'optimisation d'une thérapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2994432A1 true CA2994432A1 (fr) | 2017-03-02 |
Family
ID=58100982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2994432A Abandoned CA2994432A1 (fr) | 2015-08-27 | 2016-08-26 | Systeme d'authentification utilise dans un systeme de dialyse a base de sorbant pour l'optimisation d'une therapie |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3341042A4 (fr) |
| JP (1) | JP6777730B2 (fr) |
| CN (1) | CN108025124A (fr) |
| AU (1) | AU2016310334B2 (fr) |
| CA (1) | CA2994432A1 (fr) |
| WO (1) | WO2017035420A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6978951B2 (ja) * | 2018-01-24 | 2021-12-08 | 日機装株式会社 | 透析用ベースユニット及び透析システム |
| JP7338954B2 (ja) * | 2018-05-10 | 2023-09-05 | 日機装株式会社 | 血液浄化装置及び血液浄化装置による医療部品の判定方法 |
| ES2958742T3 (es) | 2018-07-30 | 2024-02-14 | Gambro Lundia Ab | Sistema con un dispositivo inteligente de filtración y/o difusión |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486286A (en) * | 1991-04-19 | 1996-01-23 | Althin Medical, Inc. | Apparatus for performing a self-test of kidney dialysis membrane |
| US5507723A (en) * | 1994-05-24 | 1996-04-16 | Baxter International, Inc. | Method and system for optimizing dialysis clearance |
| US8011905B2 (en) * | 2005-11-17 | 2011-09-06 | Novartis Ag | Surgical cassette |
| US8330579B2 (en) * | 2007-07-05 | 2012-12-11 | Baxter International Inc. | Radio-frequency auto-identification system for dialysis systems |
| US8882700B2 (en) * | 2008-05-02 | 2014-11-11 | Baxter International Inc. | Smart patient transfer set for peritoneal dialysis |
| US9020827B2 (en) * | 2009-10-16 | 2015-04-28 | Baxter International Inc. | Peritoneal dialysis optimized using a patient hand-held scanning device |
| US10799117B2 (en) * | 2009-11-05 | 2020-10-13 | Fresenius Medical Care Holdings, Inc. | Patient treatment and monitoring systems and methods with cause inferencing |
| US8539573B2 (en) * | 2010-02-19 | 2013-09-17 | Fenwal, Inc. | Authorization scheme to minimize the use of unauthorized medical device disposables on a medical device instrument |
| DE102010022201A1 (de) * | 2010-05-20 | 2011-11-24 | Fresenius Medical Care Deutschland Gmbh | Medizinische Behandlungsanordnung |
| WO2013070172A1 (fr) * | 2011-11-08 | 2013-05-16 | Temasek Polytechnic | Système de détection permettant de détecter une substance dans un dialysat |
| US9603995B2 (en) * | 2013-03-15 | 2017-03-28 | Tandem Diabetes Care. Inc. | Device and method for setting therapeutic parameters for an infusion device |
| US9764076B2 (en) * | 2014-02-26 | 2017-09-19 | Medtronic, Inc. | Authentication system utilized in a sorbent-based dialysis system for therapy optimization |
| US9764073B2 (en) * | 2014-02-26 | 2017-09-19 | Medtronic, Inc. | Authentication and tracking system |
-
2016
- 2016-08-26 CN CN201680049864.XA patent/CN108025124A/zh active Pending
- 2016-08-26 CA CA2994432A patent/CA2994432A1/fr not_active Abandoned
- 2016-08-26 JP JP2018510451A patent/JP6777730B2/ja active Active
- 2016-08-26 WO PCT/US2016/048814 patent/WO2017035420A1/fr not_active Ceased
- 2016-08-26 EP EP16840175.0A patent/EP3341042A4/fr not_active Ceased
- 2016-08-26 AU AU2016310334A patent/AU2016310334B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3341042A1 (fr) | 2018-07-04 |
| AU2016310334B2 (en) | 2020-07-09 |
| JP2018525141A (ja) | 2018-09-06 |
| AU2016310334A1 (en) | 2018-03-22 |
| WO2017035420A1 (fr) | 2017-03-02 |
| CN108025124A (zh) | 2018-05-11 |
| WO2017035420A4 (fr) | 2017-04-27 |
| EP3341042A4 (fr) | 2019-04-17 |
| JP6777730B2 (ja) | 2020-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9764076B2 (en) | Authentication system utilized in a sorbent-based dialysis system for therapy optimization | |
| CN107596469B (zh) | 验证和追踪系统 | |
| US20230226262A1 (en) | Optimizing peritoneal dialysis using a patient hand-held scanning device | |
| KR101122439B1 (ko) | 유체 처리 의료 장치 및 유체 처리 의료 장치를 셋업하기 위한 방법 | |
| KR101934685B1 (ko) | 치료 처방 그리고 추적, 서비스, 및 재고 조사를 위한 가정용 의료 장치 시스템 및 방법 | |
| AU2016326298B2 (en) | Short-range wireless communication for a dialysis system | |
| US20130345623A1 (en) | Device and method for creation and display of graphic coding specific for medical devices and medical treatments | |
| EP3600483B1 (fr) | Cassette de dialyse avec une puce rfid | |
| AU2016310334B2 (en) | Authentication system utilized in a sorbent-based dialysis system for therapy optimization | |
| JP4734343B2 (ja) | 医療アプリケーションに関する溶液準備のための浄化システム |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20221116 |
|
| FZDE | Discontinued |
Effective date: 20221116 |
|
| FZDE | Discontinued |
Effective date: 20221116 |